LT6974B - Cleanser for skin care and preparation method thereof - Google Patents
Cleanser for skin care and preparation method thereof Download PDFInfo
- Publication number
- LT6974B LT6974B LT2021530A LT2021530A LT6974B LT 6974 B LT6974 B LT 6974B LT 2021530 A LT2021530 A LT 2021530A LT 2021530 A LT2021530 A LT 2021530A LT 6974 B LT6974 B LT 6974B
- Authority
- LT
- Lithuania
- Prior art keywords
- weight
- skin
- cleanser
- poured
- homogenizer
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title 1
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 claims abstract description 30
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 claims abstract description 29
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims abstract description 23
- 235000012209 glucono delta-lactone Nutrition 0.000 claims abstract description 20
- 229960003681 gluconolactone Drugs 0.000 claims abstract description 20
- PHOQVHQSTUBQQK-SQOUGZDYSA-N D-glucono-1,5-lactone Chemical compound OC[C@H]1OC(=O)[C@H](O)[C@@H](O)[C@@H]1O PHOQVHQSTUBQQK-SQOUGZDYSA-N 0.000 claims abstract description 19
- 208000002874 Acne Vulgaris Diseases 0.000 claims abstract description 18
- 206010000496 acne Diseases 0.000 claims abstract description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 18
- XPCTZQVDEJYUGT-UHFFFAOYSA-N 3-hydroxy-2-methyl-4-pyrone Chemical compound CC=1OC=CC(=O)C=1O XPCTZQVDEJYUGT-UHFFFAOYSA-N 0.000 claims abstract description 15
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 claims abstract description 15
- 229960004889 salicylic acid Drugs 0.000 claims abstract description 15
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 14
- 239000002253 acid Substances 0.000 claims abstract description 11
- 239000008367 deionised water Substances 0.000 claims abstract description 11
- 229910021641 deionized water Inorganic materials 0.000 claims abstract description 11
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims abstract description 9
- HYMLWHLQFGRFIY-UHFFFAOYSA-N Maltol Natural products CC1OC=CC(=O)C1=O HYMLWHLQFGRFIY-UHFFFAOYSA-N 0.000 claims abstract description 8
- 229940043353 maltol Drugs 0.000 claims abstract description 8
- 239000000230 xanthan gum Substances 0.000 claims abstract description 6
- 229920001285 xanthan gum Polymers 0.000 claims abstract description 6
- 229940082509 xanthan gum Drugs 0.000 claims abstract description 6
- 235000010493 xanthan gum Nutrition 0.000 claims abstract description 6
- 229940047642 disodium cocoamphodiacetate Drugs 0.000 claims abstract description 5
- 239000011780 sodium chloride Substances 0.000 claims abstract description 5
- 239000000203 mixture Substances 0.000 claims description 12
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 9
- 239000003599 detergent Substances 0.000 claims description 8
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 238000003756 stirring Methods 0.000 claims description 7
- 235000011187 glycerol Nutrition 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 239000002994 raw material Substances 0.000 claims description 5
- 229910000000 metal hydroxide Inorganic materials 0.000 claims description 3
- 150000004692 metal hydroxides Chemical class 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- YIKYNHJUKRTCJL-UHFFFAOYSA-N Ethyl maltol Chemical compound CCC=1OC=CC(=O)C=1O YIKYNHJUKRTCJL-UHFFFAOYSA-N 0.000 claims description 2
- 229940093503 ethyl maltol Drugs 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 230000002265 prevention Effects 0.000 claims description 2
- 238000001223 reverse osmosis Methods 0.000 claims description 2
- 238000000034 method Methods 0.000 claims 4
- 229910019142 PO4 Inorganic materials 0.000 claims 2
- 239000010452 phosphate Substances 0.000 claims 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims 2
- 239000004615 ingredient Substances 0.000 claims 1
- 210000003491 skin Anatomy 0.000 abstract description 42
- 239000002537 cosmetic Substances 0.000 abstract description 8
- 239000011148 porous material Substances 0.000 abstract description 7
- 229960004275 glycolic acid Drugs 0.000 abstract description 6
- 241000894006 Bacteria Species 0.000 abstract description 5
- 210000004927 skin cell Anatomy 0.000 abstract description 5
- 230000001815 facial effect Effects 0.000 abstract description 3
- 230000008929 regeneration Effects 0.000 abstract description 3
- 238000011069 regeneration method Methods 0.000 abstract description 3
- 239000004480 active ingredient Substances 0.000 abstract description 2
- 150000007513 acids Chemical class 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 230000008092 positive effect Effects 0.000 description 4
- 229920001273 Polyhydroxy acid Polymers 0.000 description 3
- 229940061720 alpha hydroxy acid Drugs 0.000 description 3
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 150000001277 beta hydroxy acids Chemical class 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 1
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- -1 BHA acids Chemical class 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 229920000289 Polyquaternium Polymers 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 1
- 230000003255 anti-acne Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229940036350 bisabolol Drugs 0.000 description 1
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 1
- 238000009924 canning Methods 0.000 description 1
- 125000002843 carboxylic acid group Chemical group 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 229960004106 citric acid Drugs 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000001530 keratinolytic effect Effects 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229960000448 lactic acid Drugs 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 229940101267 panthenol Drugs 0.000 description 1
- 235000020957 pantothenol Nutrition 0.000 description 1
- 239000011619 pantothenol Substances 0.000 description 1
- 229940055729 papain Drugs 0.000 description 1
- 235000019834 papain Nutrition 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 229910000406 trisodium phosphate Inorganic materials 0.000 description 1
- 235000019801 trisodium phosphate Nutrition 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
IŠRADIMO SRITISFIELD OF THE INVENTION
Išradimas skirtas kosmetikos pramonei, konkrečiai - giliai poras valančiam aktyviajam prausikliui, kurio pagrindiniai aktyvieji komponentai yra glikolio rūgštis, salicilo rūgštis ir gliukonolaktonas. Prausiklis skirtas kasdienei odos priežiūrai, jo paskirtis - nuvalyti ant odos paviršiaus esančius nešvarumus, kosmetikos likučius, negyvas odos ląsteles, išvalyti poras, teigiamai veikti nuo aknės kenčiančią odos būklę, skatinti viršutinio odos sluoksnio regeneraciją. Dėl parinktos optimalios rūgščių koncentracijos, naudojimo metu prausiklis sukuria nepalankią terpę bakterijų dauginimuisi odos paviršiuje, tačiau tuo pačiu ir nedirgina veido odos, nesukelia paraudimo.The invention is intended for the cosmetic industry, specifically for a deep pore-cleansing active cleanser, the main active components of which are glycolic acid, salicylic acid and gluconolactone. The cleanser is intended for daily skin care, its purpose is to clean the dirt on the surface of the skin, cosmetic residues, dead skin cells, clean the pores, have a positive effect on the condition of the skin suffering from acne, and promote the regeneration of the upper layer of the skin. Due to the selected optimal concentration of acids, during use, the cleanser creates an unfavorable environment for the reproduction of bacteria on the surface of the skin, but at the same time, it does not irritate the skin of the face and does not cause redness.
TECHNIKOS LYGISSTATE OF THE ART
Aknė yra neabejotinai dažniausia odos liga visame pasaulyje. Apskaičiuota, kad apie 85% gyventojų nuo 11 iki 30 metų kenčia nuo spuogų. Spuogų priežastis tiksliai nežinoma dėl to, kad kartu veikia daugybė veiksnių, tačiau tarp jų verta paminėti genetinį veiksnį, kuris kartu su endokrininiais, uždegiminiais ir infekciniais veiksniais iššaukia aknę. Spuogai ypatingai išryškėja paauglystės metu, bet gali pasitaikyti įvairaus amžiaus žmonėms. Veidas, pečiai, nugara, kaklas, krūtinė, viršutinė rankų dalis yra vietos, kuriose dažniausiai pasireiškia aknė.Acne is undoubtedly the most common skin disease worldwide. It is estimated that about 85% of the population between the ages of 11 and 30 suffer from acne. The exact cause of acne is unknown due to the interaction of many factors, but among them it is worth mentioning the genetic factor, which together with endocrine, inflammatory and infectious factors provokes acne. Acne is particularly prominent during adolescence, but it can occur in people of all ages. The face, shoulders, back, neck, chest, upper arms are the most common places where acne occurs.
Yra išrasta ir sukurta daugybė kosmetikos produktų, skirtų odos priežiūrai, prevenciškai apsaugančių nuo aknės. Rusijos patente Nr. RU2678307 aprašytas aktyvus kosmetikos produktas nuo spuogų, kurio sudėtyje yra glicerino, salicilo rūgšties, glikolio rūgšties, pieno rūgšties, papaino, citrinos rūgšties, hialurono rūgšties, retinolio, alantoino, niacinamido, pantenolio, bisabololio, papildantis produktų, skirtų odos priežiūrai, spektrą.Many cosmetic products have been invented and developed for skin care and acne prevention. Russian patent no. RU2678307 describes an active anti-acne cosmetic product containing glycerin, salicylic acid, glycolic acid, lactic acid, papain, citric acid, hyaluronic acid, retinol, allantoin, niacinamide, panthenol, bisabolol to complement the range of skin care products.
Europos patente Nr. EP3367995 aprašyta odos priežiūros kompozicija, apimanti vitaminą C ir gliukonolaktoną, kur 95 % kompozicijos masės sudaro vanduo. Vitaminas C ir gliukonolaktonas yra dariniai, plačiai naudojami kosmetikoje. Gliukonolaktonas yra rūgštinis junginys, kuris, būdamas kompozicijoje, stabdo odos senėjimą, pavyzdžiui, sumažina raukšles. Gliukonolaktonas turi didesnę molekulinę struktūrą nei daugelis alfa- ir (arba) beta-hidroksikarbolio rūgščių, naudojamų odos priežiūros kompozicijose. Manoma, kad gliukonolaktono veiksmingumas yra optimalus, esant žemesnėms pH vertėms.European patent no. EP3367995 describes a skin care composition comprising vitamin C and gluconolactone, wherein 95% by weight of the composition is water. Vitamin C and gluconolactone are derivatives widely used in cosmetics. Gluconolactone is an acidic compound that, being in the composition, slows down the aging of the skin, for example, reduces wrinkles. Gluconolactone has a larger molecular structure than many alpha- and/or beta-hydroxycarbolic acids used in skin care formulations. Gluconolactone is believed to be optimally effective at lower pH values.
TRUMPAS IŠRADIMO ESMĖS APRAŠYMASBRIEF DESCRIPTION OF THE ESSENCE OF THE INVENTION
Šiame išradime atskleista alternatyvi odos priežiūros priemonė, t. y. giliai poras valantis aktyvusis prausiklis, prisitaikantis prie individualių odos poreikių, kompleksiškai apimantis pagrindinius aktyvuosius komponentus: glikolio rūgštį, salicilo rūgštį ir gliukonolaktoną.The present invention discloses an alternative skin care product viz. i.e. deep pore-cleansing active cleanser that adapts to individual skin needs, complexly including the main active components: glycolic acid, salicylic acid and gluconolactone.
Glikolio rūgštis yra mažamolekulinė organinė rūgštis, priskiriama prie alfahidroksirūgščių (AHA), kadangi prie alfa anglies atomo turi funkcinę hidroksigrupę. Ši rūgštis pasižymi keratolitiniu poveikiu, eksfolijuoja odą, skatina odos atsinaujinimą, slopina aknę, teigiamai veikia nuo aknės pažeistą odą, mažina odos pigmentaciją, padeda kovojant su spuogais.Glycolic acid is a low-molecular organic acid classified as alpha hydroxy acids (AHA) because it has a functional hydroxy group at the alpha carbon atom. This acid has a keratolytic effect, exfoliates the skin, promotes skin renewal, suppresses acne, has a positive effect on acne-damaged skin, reduces skin pigmentation, and helps fight acne.
Salicilo rūgštis yra organinė rūgštis, priskiriama prie betahidroksirūgščių (BHA), kadangi šios rūgšties struktūroje esanti funkcinė hidroksigrupę yra pozicionuota prie beta anglies atomo. Remiantis moksliniais šaltiniais, ji turi priešuždegiminių ir antibakterinių savybių. Mokslinių šaltinių duomenimis salicilo rūgštis eksfolijuoja odą, skatina negyvų odos ląstelių pašalinimą, efektyviai valo odos poras. Gali skatinti ląstelių regeneraciją. Reguliuoja sebumo išsiskyrimą. Veiksminga kovojant su spuogais, daro teigiamą poveikį nuo aknės kenčiančiai odai.Salicylic acid is an organic acid classified as a beta hydroxy acid (BHA) because the functional hydroxy group in the structure of this acid is positioned at the beta carbon atom. According to scientific sources, it has anti-inflammatory and antibacterial properties. According to scientific sources, salicylic acid exfoliates the skin, promotes the removal of dead skin cells, and effectively cleans skin pores. Can promote cell regeneration. Regulates sebum secretion. Effective in fighting acne, has a positive effect on acne-prone skin.
Gliukonolaktonas yra polihidroksirūgštis (PHA), kurios molekulė turi ne vieną, o kelias funkcines karboksirūgšties grupes. Gliukonolaktonas drėkina ir sustiprina odą. Gliukonolaktono poveikis panašus į AHA, BHA rūgščių, tik švelnesnis. Į odą prasiskverbia negiliai dėl didesnio molekulės dydžio. Būtent dėl mažesnės skvarbos ši PHA švelniai veikia odą ir yra tinkama net jautrios odos savininkams.Gluconolactone is a polyhydroxy acid (PHA) whose molecule contains not one but several functional carboxylic acid groups. Gluconolactone moisturizes and strengthens the skin. The effect of gluconolactone is similar to AHA and BHA acids, only milder. Penetrates shallowly into the skin due to the larger molecular size. It is because of the lower penetration that this PHA has a gentle effect on the skin and is suitable even for owners of sensitive skin.
Kosmetikos kompozicija, apimanti visus tris pagrindinius aktyvuosius komponentus, šiuo metu nėra žinoma. Dėl parinktos optimalios rūgščių koncentracijos, naudojimo metu prausiklis sukuria nepalankią terpę bakterijų dauginimuisi odos paviršiuje, efektyviai valo poras, šalina negyvas odos ląsteles, padeda suvaldyti spuogelius, skatina paviršutinio odos sluoksnio atsinaujinimą, teigiamai veikia nuo aknės kenčiančią odą.A cosmetic composition that includes all three main active components is currently unknown. Due to the selected optimal concentration of acids, during use, the cleanser creates an unfavorable environment for the reproduction of bacteria on the surface of the skin, effectively cleans pores, removes dead skin cells, helps control acne, promotes the renewal of the superficial skin layer, and has a positive effect on skin suffering from acne.
Optimalus prausiklio pH sukuria nepalankią terpę bakterijų dauginimuisi odos paviršiuje, o subalansuota glikolio rūgšties, salicilo rūgšties ir gliukonolaktono koncentracija nedirgina veido odos ir nesukelia paraudimo.The optimal pH of the cleanser creates an unfavorable environment for the growth of bacteria on the surface of the skin, and the balanced concentration of glycolic acid, salicylic acid and gluconolactone does not irritate the facial skin and does not cause redness.
IŠSAMUS IŠRADIMO ESMĖS APRAŠYMASDETAILED DESCRIPTION OF THE ESSENCE OF THE INVENTION
Pagrindiniai aktyvieji prausiklyje esantys komponentai yra glikolio rūgštis, salicilo rūgštis ir gliukonolaktonas. Produkto sudėtyje yra 82,96 - 85,88 masės % vandens, 5 masės % glicerino, 3,6 - 5,0 masės % glikolio rūgšties, 1,0-1,5 masės % salicilo rūgšties, 1,5 masės % natrio hidroksido, 1,0 - 1,5 masės % dinatrio kokoamfodiacetato, 1,0 masės % gliukonolaktono, 0,7 - 0,9 masės % ksantano dervos, 0,2 - 0,4 masės % maltolio, 0,1 - 0,2 masės % natrio chlorido ir 0,02 - 0,04 masės % polikvaternio-80. Išsami prausiklio sudėtis ir jo sudedamųjų dalių funkcijos pateiktos 1 lentelėje.The main active ingredients in the cleanser are glycolic acid, salicylic acid and gluconolactone. The product contains 82.96 - 85.88 wt% water, 5 wt% glycerin, 3.6 - 5.0 wt% glycolic acid, 1.0-1.5 wt% salicylic acid, 1.5 wt% sodium hydroxide , 1.0 - 1.5% by weight disodium cocoamphodiacetate, 1.0% by weight gluconolactone, 0.7 - 0.9% by weight xanthan gum, 0.2 - 0.4% by weight maltol, 0.1 - 0.2 wt % sodium chloride and 0.02 - 0.04 wt % polyquaternium-80. The detailed composition of the detergent and the functions of its components are presented in Table 1.
lentelėtable
Šio išradimo giliai odos poras valančio prausiklio gamybos procedūra yra sekanti:The manufacturing procedure for the deep pore cleansing cleanser of the present invention is as follows:
1) į homogenizatorių supilama 75 % dejonizuoto vandens (nuo viso gamybos procesui numatyto vandens kiekio) ir visas kiekis maltolio ir polikvaternio80. Įjungiamas maišymas, mišinys maišant sušildomas iki 30 °C ir dar maišoma apie 20 minučių, kol ištirps žaliavos;1) 75% of deionized water (from the total amount of water provided for the production process) and the entire amount of maltol and polyquaternium 80 are poured into the homogenizer. Stirring is turned on, the mixture is heated to 30 °C while stirring and stirred for about 20 minutes until the raw materials dissolve;
2) suberiama salicilo rūgštis ir maišoma 20 minučių, palaikant 30 °C temperatūrą;2) salicylic acid is added and stirred for 20 minutes, maintaining a temperature of 30 °C;
3) į atskirą talpą supilamas glicerinas ir po to suberiama ksantano derva; homogenizuojama iki vientisos masės; taip gaunamas tirpalas B;3) glycerin is poured into a separate container and then xanthan gum is added; homogenized to a homogeneous mass; this gives solution B;
4) į homogenizatorių supilamas tirpalas B ir intensyviai maišomas 10 minučių; po to maišymo greitis sumažinamas iki vidutinio ir maišymas tęsiamas, kol bus gauta vientisa homogeniška masė;4) solution B is poured into the homogenizer and stirred intensively for 10 minutes; after that, the mixing speed is reduced to medium and the mixing is continued until a single homogeneous mass is obtained;
5) į homogenizatorių supilama pusę glikolio rūgšties kiekio ir maišoma dar 20 minučių;5) half the amount of glycolic acid is poured into the homogenizer and mixed for another 20 minutes;
6) į homogenizatorių supilamas prieš tai dejonizuotame vandenyje (apie 50,0 % nuo likučio) ištirpintas natrio hidroksidas; maišymas tęsiamas 20 minučių;6) sodium hydroxide dissolved in previously deionized water (about 50.0% of the residue) is poured into the homogenizer; stirring is continued for 20 minutes;
7) į homogenizatorių supilama likusi glikolio rūgšties dalis ir maišoma dar 20 minučių;7) the rest of the glycolic acid is poured into the homogenizer and mixed for another 20 minutes;
8) į homogenizatorių supilamas likusiame dejonizuotame vandenyje ištirpintas gliukonolaktonas; maišymas tęsiamas 20 minučių;8) gluconolactone dissolved in the remaining deionized water is poured into the homogenizer; stirring is continued for 20 minutes;
9) į homogenizatorių supilamas dinatrio kokoamfodiacetatas; maišymas tęsiamas 20 minučių;9) disodium cocoamphodiacetate is poured into the homogenizer; stirring is continued for 20 minutes;
10) patikrinamas mišinio pH, tirštumas, spalva, kvapas; paimamas mėginys tyrimams;10) pH, thickness, color, smell of the mixture are checked; a sample is taken for research;
11) pagamintas produktas išpilstomas į talpas.11) the produced product is bottled.
Gamybos procese vietoje dejonizuoto vandens galima naudoti ir atvirkštinio osmoso (RO) metodu išgrynintą vandenį.In the production process, water purified by reverse osmosis (RO) can be used instead of deionized water.
Pagaminto produkto konsistencija - pilkas-gelsvai pilkas, klampus skystis. Kvapas - lengvai saldus, gali būti šiek tiek rūgštus. Produkto pH - 3,5-5,5.The consistency of the manufactured product is gray-yellowish gray, viscous liquid. Smell - slightly sweet, can be slightly sour. Product pH - 3.5-5.5.
Pagal dar kitą prausiklio gamybos būdą, vietoje natrio chlorido galima naudoti kitas bazes (rūgščių druskas arba metalų hidroksidus), pavyzdžiui, trinatrio fosfatą, kalio hidroksidą. Vietoje maltolio galima naudoti etilmaltolį.According to yet another detergent production method, other bases (acid salts or metal hydroxides), such as trisodium phosphate, potassium hydroxide, can be used instead of sodium chloride. Ethyl maltol can be used instead of maltol.
Dėl parinktos optimalios rūgščių koncentracijos, šio išradimo prausiklis naudojimo metu sukuria nepalankią terpę bakterijų dauginimuisi odos paviršiuje, nedirgindamas veido odos ir nesukeldamas paraudimo. Praktiškai įsitikinta, kad prausiklis efektyviai valo poras, šalina negyvas odos ląsteles, skaistina odą, šviesina randų ir pigmentines dėmeles, skatina kolageno sintezę odoje, padeda suvaldyti nuo aknės kenčiančią odos būklę, skatina paviršutinio odos sluoksnio atsinaujinimą.Due to the selected optimal concentration of acids, the cleanser of this invention creates an unfavorable environment for the reproduction of bacteria on the surface of the skin during use, without irritating the skin of the face and without causing redness. It is practically certain that the cleanser effectively cleans pores, removes dead skin cells, brightens the skin, lightens scars and pigment spots, stimulates collagen synthesis in the skin, helps control acne-prone skin, and promotes the renewal of the superficial skin layer.
Produktą galima naudoti ir kaip prausiklį, ir kaip kaukę. Naudojant kaip prausiklį, nuvalius makiažą, prausiklį tepti ant sausos ar vos drėgnos odos, sukamaisiais judesiais masažuoti 1 minutę. Po to gausiai nuplauti vėsiu vandeniu. Naudojant kaip kaukę, savaitę sausą veido odą dengti plonu produkto sluoksniu, palikti 2 minutėms, po to gausiai nuplauti vėsiu vandeniu.The product can be used both as a cleanser and as a mask. When used as a cleanser, after removing make-up, apply the cleanser on dry or slightly damp skin, massaging in circular motions for 1 minute. Then rinse thoroughly with cool water. When used as a mask, apply a thin layer of the product to dry facial skin for a week, leave for 2 minutes, then rinse thoroughly with cool water.
Claims (8)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| LT2021530A LT6974B (en) | 2021-06-15 | 2021-06-15 | Cleanser for skin care and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| LT2021530A LT6974B (en) | 2021-06-15 | 2021-06-15 | Cleanser for skin care and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| LT2021530A LT2021530A (en) | 2022-12-27 |
| LT6974B true LT6974B (en) | 2023-01-25 |
Family
ID=84533329
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LT2021530A LT6974B (en) | 2021-06-15 | 2021-06-15 | Cleanser for skin care and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| LT (1) | LT6974B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025012002A1 (en) * | 2023-07-07 | 2025-01-16 | Unilever Ip Holdings B.V. | A personal care composition |
-
2021
- 2021-06-15 LT LT2021530A patent/LT6974B/en unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025012002A1 (en) * | 2023-07-07 | 2025-01-16 | Unilever Ip Holdings B.V. | A personal care composition |
Also Published As
| Publication number | Publication date |
|---|---|
| LT2021530A (en) | 2022-12-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7159288B2 (en) | A yeast-based mask that improves skin, hair and scalp health | |
| JP4280341B2 (en) | Cosmetic composition containing moisturizing plant extract | |
| JP2003002813A (en) | Skin care composition | |
| CN117137817A (en) | Residue removing composition, sensitive creatine facial cleanser and preparation method of sensitive creatine facial cleanser | |
| CN112957263A (en) | Essence, face washing towel impregnated with essence and preparation process of face washing towel | |
| JP6158471B2 (en) | Skin aging inhibitor | |
| KR102647272B1 (en) | Skin or hair detergent composition containing a naturally derived surfactant | |
| CN107684530A (en) | Acne-removing composition and preparation method thereof | |
| JP4644589B2 (en) | Negative ion water production method and negative ion water | |
| JP7590848B2 (en) | Gel-type cleansing cosmetics | |
| JP2017171625A (en) | Cleaning composition | |
| JPH11228379A (en) | Cosmetics, hygiene products and quasi-drug compositions | |
| CN119280108B (en) | Bath oil lotion with soothing effect and preparation method thereof | |
| CN115192486B (en) | Jellyfish nourishing anti-aging mask liquid composition and product thereof | |
| JP4658631B2 (en) | Bath salt composition | |
| CN105520848B (en) | A kind of plant essential oil composition with tender skin senile-resistant efficacy | |
| JPS59227999A (en) | Creamy detergent | |
| JP2020169128A (en) | Hair cleanser composition | |
| CA3096590A1 (en) | Composition derived from seawater, process for obtaining same and use thereof in cosmetic compositions | |
| JPH04321615A (en) | Skin medicine for external use | |
| CN120284769B (en) | PQQ-containing composition and application and skin care product thereof | |
| LT2021530A (en) | Cleanser for skin care and preparation method thereof | |
| LT6976B (en) | Washer for the prevention and treatment of skin diseases, including rosacea, acne and redness | |
| KR101008703B1 (en) | Exfoliation cosmetic composition | |
| KR101625597B1 (en) | Cosmetic composition for the preventing loss of hair and promoting growth of hair comprising sodium chloride scrub |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BB1A | Patent application published |
Effective date: 20221227 |
|
| FG9A | Patent granted |
Effective date: 20230125 |